BioSpace News Archive

Business

Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress

Scholar Rock today reported financial results and corporate updates for the third quarter ended September 30, 2022.

November 14, 2022
·
12 min read
Business

Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates - November 14, 2022

Stoke Therapeutics, Inc. today reported financial results for the third quarter of 2022 and provided business updates, including positive data from a planned interim analysis of the ongoing Phase 1/2a MONARCH and ADMIRAL clinical studies of STK-001 in children and adolescents with Dravet syndrome.

November 14, 2022
·
20 min read
Drug Development

Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at the American College of Rheumatology Convergence 2022

Kezar Life Sciences, Inc. today announced that it presented the complete data set from the MISSION Phase 2 clinical trial evaluating zetomipzomib in active lupus nephritis (LN) at the American College of Rheumatology (ACR) Convergence 2022 in Philadelphia, PA.

November 14, 2022
·
10 min read
Business

Castle Biosciences Named a Houston Chronicle Top Workplace for the Second Consecutive Year

Castle Biosciences, Inc. has been named a Houston Chronicle Top Workplace for the second year in a row.

November 14, 2022
·
3 min read
Business

Evaxion Announces Third Quarter 2022 Financial Results and Business Update

Evaxion Biotech A/S announced its third quarter 2022 financial results and provided an operational and business update.

November 14, 2022
·
9 min read
Business

POINT Biopharma Reports Third Quarter 2022 Financial Results and Announces Strategic Collaboration and Exclusive License Agreements with Lantheus Holdings

POINT Biopharma Global Inc. today announced financial results for the third quarter ended September 30, 2022, and provided an update on business highlights, including the announcement of a strategic collaboration and exclusive license agreements with Lantheus Holdings Inc.

November 14, 2022
·
13 min read
Deals

TriSalus Life Sciences to Become Publicly Traded Through Merger With MedTech Acquisition Corporation

TriSalus Life Sciences® announced it has entered into a definitive merger agreement with MedTech Acquisition Corporation, a publicly traded special purpose acquisition company.

November 14, 2022
·
19 min read
Business

Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update

Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today provided a business update and reported financial results for the quarter ended September 30, 2022.

November 14, 2022
·
20 min read
Business

Gracell Biotechnologies Reports Third Quarter 2022 Unaudited Financial Results and Provides Corporate Update

Gracell Biotechnologies Inc. today reported third quarter unaudited financial results for the period ended September 30, 2022, and provided corporate updates.

November 14, 2022
·
12 min read
Business

Enanta Pharmaceuticals to Host Conference Call on November 21 at 4:30 p.m. ET to Discuss its Financial Results for Its Fiscal Fourth Quarter and Full Year Ended September 30, 2022

Enanta Pharmaceuticals, Inc. today announced that it plans to report its financial results for its fiscal fourth quarter and full year ended September 30, 2022 after the U.S. market closes on November 21, 2022.

November 14, 2022
·
1 min read